Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bethany B Moore

Showing results (61-70 of 219) with videos related to

Pageof 22
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2007
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseasesRagini Vittal, Hengmin Zhang, Meilan K Han, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 26, 2005
Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in miceDavid E Nethery, Bethany B Moore, George Minowada, et al.
American Journal of Respiratory Cell and Molecular Biology|March 26, 2013
Animal models of fibrotic lung diseaseBethany B Moore, William E Lawson, Tim D Oury, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 1, 2014
γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosisShanna L Ashley, Yangjin Jegal, Thomas A Moore, et al.
American Journal of Respiratory Cell and Molecular Biology|May 10, 2003
Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevationJill E Kolodsick, Marc Peters-Golden, Jose Larios, et al.
JCI Insight|January 25, 2021
Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathologyStephen J Gurczynski, Nicolas L Pereira, Steven M Hrycaj, et al.
Pediatric Blood & Cancer|April 25, 2007
The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantationGerhard C Hildebrandt, Sung W Choi, Gunnar Mueller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2013
Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplantRacquel Domingo-Gonzalez, Samuel Katz, C Henrique Serezani, et al.
American Journal of Respiratory Cell and Molecular Biology|June 23, 2007
Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidaseCarlos H Serezani, Jooho Chung, Megan N Ballinger, et al.
Journal of Immunology Research|August 21, 2023
IL-17: Balancing Protective Immunity and PathogenesisLu Sun, Lufei Wang, Bethany B Moore, et al.
Pageof 22

Showing results (61-70 of 219) with videos related to

Sort By:
Pageof 22
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2007
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseasesRagini Vittal, Hengmin Zhang, Meilan K Han, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 26, 2005
Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in miceDavid E Nethery, Bethany B Moore, George Minowada, et al.
American Journal of Respiratory Cell and Molecular Biology|March 26, 2013
Animal models of fibrotic lung diseaseBethany B Moore, William E Lawson, Tim D Oury, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 1, 2014
γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosisShanna L Ashley, Yangjin Jegal, Thomas A Moore, et al.
American Journal of Respiratory Cell and Molecular Biology|May 10, 2003
Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevationJill E Kolodsick, Marc Peters-Golden, Jose Larios, et al.
JCI Insight|January 25, 2021
Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathologyStephen J Gurczynski, Nicolas L Pereira, Steven M Hrycaj, et al.
Pediatric Blood & Cancer|April 25, 2007
The absence of donor-derived IL-13 exacerbates the severity of acute graft-versus-host disease following allogeneic bone marrow transplantationGerhard C Hildebrandt, Sung W Choi, Gunnar Mueller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2013
Prostaglandin E2-induced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplantRacquel Domingo-Gonzalez, Samuel Katz, C Henrique Serezani, et al.
American Journal of Respiratory Cell and Molecular Biology|June 23, 2007
Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidaseCarlos H Serezani, Jooho Chung, Megan N Ballinger, et al.
Journal of Immunology Research|August 21, 2023
IL-17: Balancing Protective Immunity and PathogenesisLu Sun, Lufei Wang, Bethany B Moore, et al.
Pageof 22